title: Distribution of mobilized progenitor cells in the buffy coat of the haemonetics MCS3p cell separator: a study to optimize the collection of progenitors by leukapheresis.
abstract: Hematopoietic progenitor and stem cells for transplantation can be mobilized into the circulation and collected by leukapheresis. In this procedure, the leukocytes are distributed in the buffy coat along a density gradient, and the composition of the final product depends on which layer was collected. For the Haemonetics MCS3p Cell Separator, the manufacturer recommended starting the progenitor cell collection at a light transmission of 30%-40% (compared with plasma) and continue it for 40-50 ml. To optimize the use of this machine, the buffy coat it produces was studied in 12 patients by collecting it in fractions of increasing specific weight. Each fraction was analyzed by morphology, immunocytometry, and cell culture. We found that the buffy coat uniformly contains 8 times more leukocytes than blood, but the proportion of each white cell type varies along a gradient. The lymphocyte-predominant lighter layers are richer in CD34+ cells when compared with the granulocyte-predominant denser layers (6-14 times versus 2-4 times more than blood). The majority of CD34+ cells are found at a light transmission of 10%-70% (hematocrit 6-9). We conclude that cells for transplantation should be collected in a lighter fraction of the buffy coat than originally suggested by the manufacturer.
authors.affiliation: Servizio Oncologico Cantonale, Bellinzona, Switzerland.
authors.forename: M
authors.initials: M
authors.lastname: Ghielmini
authors.forename: U
authors.initials: U
authors.lastname: Pfister
authors.forename: E
authors.initials: E
authors.lastname: Zucca
authors.forename: S
authors.initials: S
authors.lastname: van den Bosch
authors.forename: P
authors.initials: P
authors.lastname: Tamásy
authors.forename: G
authors.initials: G
authors.lastname: Marangoni
authors.forename: G
authors.initials: G
authors.lastname: Bertoli
authors.forename: J L
authors.initials: JL
authors.lastname: Derivaz
authors.forename: F
authors.initials: F
authors.lastname: Cavalli
mesh_terms: D015703:Antigens, CD / Q000097:blood; D018952:Antigens, CD34 / Q000097:blood; D004867:Equipment Design; D004906:Erythrocyte Count; D006400:Hematocrit; D006412:Hematopoietic Stem Cells / Q000473:pathology*; D006689:Hodgkin Disease / Q000097:blood / Q000628:therapy; D006801:Humans; D007937:Leukapheresis / Q000295:instrumentation* / Q000379:methods; D007938:Leukemia / Q000097:blood / Q000628:therapy*; D007958:Leukocyte Count; D008223:Lymphoma / Q000097:blood / Q000628:therapy*; D010976:Platelet Count; D012008:Recurrence
chemical_list: D015703:Antigens, CD; D018952:Antigens, CD34